Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients
Status:
COMPLETED
Trial end date:
2024-12-20
Target enrollment:
Participant gender:
Summary
Qlaris Phase 2 clinical study investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in combination with latanoprost in open-angle glaucoma (OAG) and/or ocular hypertension (OHT) patients.